Cresset Asset Management »

Stoke Therapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $771k 33k 23.50

More positions owned by Cresset Asset Management

Arista Networks Com Shs (ANET)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Erie Indty Cl A (ERIE)
Ishares Tr Core S&p500 Etf (IVV)
Reddit Cl A Put Option (RDDT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core Msci Eafe (IEFA)
Palantir Technologies Cl A Put Option (PLTR)
Ishares Tr Core S&p Scp Etf Put Option (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Put Option (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)

View all positions for Cresset Asset Management

Top funds holding Stoke Therapeutics

FMR
BlackRock
Lynx1 Capital Management
Rtw Investments
Baker Bros. Advisors
Redmile Group
Morgan Stanley
Toronto-Dominion Bank
Vanguard Group
Skorpios Trust
Siren
BVF
State Street Corporation
Polar Capital Holdings
Point72 Asset Management

View all funds holding Stoke Therapeutics